REFERENCES
- Anonymous (1983). Pyrimethamine combinations in pregnancy. Lancet, ii, 1005–1007.
- Archibald, H. M. & Robertson, A. M. (1959). Further field trials of modern antimalarials. Journal of Tropical Medicine and Hygiene, 62, 241–244.
- Bishop, A. & Birkett, B. (1947). Acquired resistance to Paludrine in Plasmodium gallinaceum. Nature, 159, 884–885.
- Bottiger, L. E., Furhoff, A. K. & Holmberg, L. (1979). Fatal reactions to drugs. Acta Medica Scandinavica, 205, 451–156.
- Bruce-Chwatt, L. J., Black, R. H., Canfield, C. J., Clyde, D. F., Peters, W. & Wernsdorfer, W. H. (1981). Chemotherapy of Malaria, 2nd Edn. WHO Monograph Series, No. 27.
- Charles, L. J. (1961). Field trials with chlorproguanil in the prophylaxis of malaria in Ghana. Bulletin of the World Health Organization, 24, 457–463.
- Communicable Disease Report (1983). Malaria prophylaxis for long-term visitors. CDR 83/35.
- Davey, D. G. & Robertson, G. I. (1957). Experiments with antimalarial drugs in man, IV. An experiment to investigate the prophylactic value of proguanil against a strain of Plasmodium falciparum known to be resistant to therapeutic treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene, 51, 463–466.
- Fairley, N. H. (1946). Researches on Paludrine (M 4888) in malaria. An experimental investigation undertaken by the LHQ, Medical Research Unit (AIF), Cairns, Australia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 40, 105–162.
- Fink, E. (1974). Assessment of causal prophylactic activity in Plasmodium berghei yoelii and its value for the development of new antimalarial drugs. Bulletin of the World Health Organization, 50, 213–222.
- Hawking, F. & Perry, N. L. M. (1948). Resistance to proguanil (Paludrine) in a mammalian malaria parasite. Lancet, 2, 850.
- Peters, W. (1970). Chemotherapy and Drug Resistance in Malaria. London: Academic Press.
- Peters, W. (1982). Antimalarial drug resistance: an increasing problem. British Medical Bulletin, 38, 187–192.
- Peters, W. (1983). Current trends in malaria chemoprophylaxis and treatment. Bulletin de la Société de Pathologie Exotique, 76, 446–454.
- Peters, W., Portus, J. & Robinson, B. L. (1977). The chemotherapy of rodent malaria, XXVIII. The development of resistance to mefloquine (WR 142,490). Annals of Tropical Medicine and Parasitology, 71, 419–427.
- Rabinovich, S. A. (1965). Experimental investigations of antimalarial drug Haloquine, III. Investigation of the possibility to restrain the development of chimoresistance to chloridine (Daraprim) by combined administration of chloridine with Haloquine. Meditsinskaya Parazitologiya i Parazitarnye Bolezni, 34, 434–439.
- Robertson, G. I. (1957). Experiments with antimalarial drugs in man, III. Experiments with compound 5943. Transactions of the Royal Society of Tropical Medicine and Hygiene, 51, 457–462.
- Schmidt, L. H., Genther, C. S., Fradkin, R. & Squires, W. (1949). Development of resistance to chlorguanide (Paludrine) during treatment of infections with Plasmodium cynomolgi. Journal of Pharmacology, 95, 382–398.
- Seaton, D. R. & Adams, A. R. D. (1949). Acquired resistance to proguanil in Plasmodium falciparum. Lancet, 2, 323–324.
- Seaton, D. R. & Lourie, E. M. (1949). Acquired resistance to proguanil (Paludrine) in Plasmodium vivax. Lancet, 1, 394–395.
- Williamson, J., Bertram, D. S. & Lourie, E. M. (1947). Effects of Paludrine and other antimalarials. Mature, 159, 885–886.